CoChat

Prevalence and predictors of medication non-adherence among people living with multimorbidity: a systematic review and meta-analysis

Open access
Foley, Louise, Larkin, James, Lombard-Vance, Richard, Murphy, Andrew W, Hynes, Lisa, Galvin, Emer, Molloy, Gerard J · 2021 · BMJ Open
Cited by 208

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Objectives: This systematic review aimed to describe medication non-adherence among people living with multimorbidity according to the current literature, and synthesise predictors of non-adherence in this population. Methods: A systematic review was conducted according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses. PubMed, EMBASE, CINAHL and PsycINFO were searched for relevant articles published in English language between January 2009 and April 2019. Quantitative studies reporting medication non-adherence and/or predictors of non-adherence among people with two or more chronic conditions were included in the review. A meta-analysis was conducted with a subgroup of studies that used an inclusive definition of multimorbidity to recruit participants, rather than seeking people with specific conditions. Remaining studies reporting prevalence and predictors of non-adherence were narratively synthesised. Results: The database search produced 10 998 records and a further 75 were identified through other sources. Following full-text screening, 178 studies were included in the review. The range of reported non-adherence differed by measurement method, at 76.5% for self-report, 69.4% for pharmacy data, and 44.1% for electronic monitoring. A meta-analysis was conducted with eight studies ( n =8949) that used an inclusive definition of multimorbidity to recruit participants. The pooled prevalence of non-adherence was 42.6% (95% CI: 34.0 - 51.3%, k =8, I 2 =97%, p <0.01). The overall range of non-adherence was 7.0%–83.5%. Frequently reported correlates of non-adherence included previous non-adherence and treatment-related beliefs. Conclusions: The review identified a heterogeneous literature in terms of conditions studied, and definitions and measures of non-adherence used. Results suggest that future attempts to improve adherence among people with multimorbidity should determine for which conditions individuals require most support. The variable levels of medication non-adherence highlight the need for more attention to be paid by healthcare providers to the impact of multimorbidity on chronic disease self-management. PROSPERO registration number: CRD42019133849.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmjopen-2020-044987

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 194

  1. 10.1093/pubmed/fdq057 · DOI
  2. 10.1093/fampra/cmr013 · DOI · Paper page
  3. 10.1370/afm.4 · DOI · Paper page
  4. 10.1007/s00228-013-1639-9 · DOI · Paper page
  5. Zelko, 2016, Medication adherence in elderly with polypharmacy living at home: a systematic review of existing studies, Mater Sociomed, 28, 129, 10.5455/msm.2016.28.129-132 · DOI
  6. Inauen, 2017, Assessing adherence to multiple medications and in daily life among patients with multimorbidity, Psychol Health, 32, 1233, 10.1080/08870446.2016.1275632 · DOI
  7. 10.1111/j.1365-2648.2008.04656.x · DOI · Paper page
  8. 10.1371/journal.pmed.1000097 · DOI · Paper page
  9. Foley, 2019, Prevalence and predictors of medication non-adherence among patients with multimorbidity: a systematic review protocol, HRB Open Res, 2, 10.12688/hrbopenres.12961.1 · DOI
  10. Xu, 2017, Mapping the global research landscape and knowledge gaps on multimorbidity: a bibliometric study, J Glob Health, 7, 10.7189/jogh.07.010414 · DOI
  11. Veritas Health Innovation . Covidence systematic review software. Melbourne, Australia; 2020.
  12. 10.1002/sim.1186 · DOI · Paper page
  13. Gaudiano, 2017, Valued living and its relationship to medication adherence in patients with bipolar and comorbid substance use disorders, J Nerv Ment Dis, 205, 178, 10.1097/NMD.0000000000000533 · DOI
  14. 10.1097/MJT.0b013e31816b69bc · DOI
  15. Albrecht, 2017, Adherence and healthcare utilization among older adults with COPD and depression, Respir Med, 129, 53, 10.1016/j.rmed.2017.06.002 · DOI
  16. Albrecht, 2016, Adherence to maintenance medications among older adults with chronic obstructive pulmonary disease. The role of depression, Ann Am Thorac Soc, 13, 1497, 10.1513/AnnalsATS.201602-136OC · DOI
  17. 10.1097/MLR.0b013e31829fa8ed · DOI
  18. 10.1089/apc.2008.0181 · DOI
  19. 10.1007/s10461-008-9441-x · DOI
  20. Axon, 2016, Comorbid depression is differentially associated with longitudinal medication nonadherence by race/ethnicity in patients with type 2 diabetes, Medicine, 95, 10.1097/MD.0000000000003983 · DOI
  21. Baca-Garcia, 2009, Treatment of depressed bipolar patients with alcohol use disorders: plenty of room for improvement, J Affect Disord, 115, 262, 10.1016/j.jad.2008.09.012 · DOI
  22. Badiee, 2012, Approaches to identifying appropriate medication adherence assessments for HIV infected individuals with comorbid bipolar disorder, AIDS Patient Care STDS, 26, 388, 10.1089/apc.2011.0447 · DOI
  23. Baik, 2012, The effect of the US Medicare Part D coverage gaps on medication use among patients with depression and heart failure, J Ment Health Policy Econ, 15, 105
  24. Banegas, 2018, Patterns of medication adherence in a multi-ethnic cohort of prevalent statin users diagnosed with breast, prostate, or colorectal cancer, J Cancer Surviv, 12, 794, 10.1007/s11764-018-0716-6 · DOI
  25. Batchelder, 2014, Differential medication nonadherence and illness beliefs in co-morbid HIV and type 2 diabetes, J Behav Med, 37, 266, 10.1007/s10865-012-9486-1 · DOI
  26. 10.1007/s11606-013-2402-8 · DOI
  27. 10.1097/MLR.0000000000000292 · DOI
  28. 10.2146/ajhp080238 · DOI · Paper page
  29. Berg, 2018, Mental health is a risk factor for poor outcomes in cardiac patients: findings from the National DenHeart survey, J Psychosom Res, 112, 66, 10.1016/j.jpsychores.2018.07.002 · DOI
  30. Bifftu, 2015, Depression among people with epilepsy in Northwest Ethiopia: a cross-sectional institution based study, BMC Res Notes, 8, 10.1186/s13104-015-1515-z · DOI
  31. 10.1007/s10461-014-0925-6 · DOI · Paper page
  32. Bogner, 2013, Measuring concurrent oral hypoglycemic and antidepressant adherence and clinical outcomes, Am J Manag Care, 19, e85
  33. Cabrera-Marroquín, 2014, Major depressive episodes are associated with poor concordance with therapy in rheumatoid arthritis patients: the impact on disease outcomes, Clin Exp Rheumatol, 32, 904
  34. 10.1016/j.ijcard.2016.01.069 · DOI
  35. 10.1007/s10549-013-2424-2 · DOI
  36. 10.1002/pds.3660 · DOI
  37. Calip, 2017, Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemia among breast cancer survivors, Breast Cancer Res Treat, 161, 161, 10.1007/s10549-016-4043-1 · DOI
  38. Cantudo-Cuenca, 2014, Concurrent use of comedications reduces adherence to antiretroviral therapy among HIV-infected patients, J Manag Care Spec Pharm, 20, 844
  39. 10.1177/0091217415621267 · DOI
  40. 10.1002/PDS.3424 · DOI
  41. 10.1177/0145721712450923 · DOI
  42. Chou, 2017, Assessing disruptions in adherence to antidepressant treatments after breast cancer diagnosis, Pharmacoepidemiol Drug Saf, 26, 676, 10.1002/pds.4198 · DOI
  43. Cicolini, 2016, Self-Reported medication adherence and beliefs among elderly in multi-treatment: a cross-sectional study, Appl Nurs Res, 30, 131, 10.1016/j.apnr.2015.11.011 · DOI
  44. 10.1016/j.cct.2013.07.010 · DOI
  45. 10.1007/s11606-014-3072-x · DOI
  46. 10.1007/s12160-011-9322-9 · DOI
  47. Cziraky, 2015, Clinical outcomes and medication adherence in acute coronary syndrome patients with and without type 2 diabetes mellitus: a longitudinal analysis 2006-2011, J Manag Care Spec Pharm, 21, 470
  48. Daniali, 2018, The prevalence of depression and its association with self-management behaviors in chronic disease patients, Iran J Psychiatry, 13
  49. 10.1177/0956462414535207 · DOI
  50. Davis, 2011, Limitations of analyses based on achieved blood pressure: lessons from the African American study of kidney disease and hypertension trial, Hypertension, 57, 1061, 10.1161/HYPERTENSIONAHA.111.169367 · DOI · Paper page
  51. 10.3122/jabfm.2015.06.150010 · DOI
  52. Desai, 2014, Adherence to oral diabetes medications among users and nonusers of antipsychotic medication, Psychiatr Serv, 65, 215, 10.1176/appi.ps.201300118 · DOI
  53. Dhamane, 2017, Association between adherence to medications for COPD and medications for other chronic conditions in COPD patients, Int J Chron Obstruct Pulmon Dis, 12, 115, 10.2147/COPD.S114802 · DOI
  54. Domino, 2014, Heterogeneity in the quality of care for patients with multiple chronic conditions by psychiatric comorbidity, Med Care, 52 Suppl 3, S101, 10.1097/MLR.0000000000000024 · DOI · Paper page
  55. DuChane, 2014, Impact of HIV-specialized pharmacies on adherence to medications for comorbid conditions, J Am Pharm Assoc, 54, 493, 10.1331/JAPhA.2014.13165 · DOI
  56. Eton, 2017, Healthcare provider relational quality is associated with better self-management and less treatment burden in people with multiple chronic conditions, Patient Prefer Adherence, 11, 1635, 10.2147/PPA.S145942 · DOI
  57. Farley, 2012, Antipsychotic adherence and its correlation to health outcomes for chronic comorbid conditions, Prim Care Companion CNS Disord, 14, m01324
  58. Ferguson, 2017, Multi-morbidity, frailty and self-care: important considerations in treatment with anticoagulation drugs. outcomes of the AFASTER study, Eur J Cardiovasc Nurs, 16, 113, 10.1177/1474515116642604 · DOI
  59. Foguet-Boreu, 2017, Pharmacological control of diabetes and hypertension comorbidity in the elderly: A study of "real world" data, Prim Care Diabetes, 11, 348, 10.1016/j.pcd.2017.03.007 · DOI
  60. Gathright, 2017, The impact of medication nonadherence on the relationship between mortality risk and depression in heart failure, Health Psychol, 36, 839, 10.1037/hea0000529 · DOI
  61. Gaynes, 2015, Psychiatric comorbidity in depressed HIV-infected individuals: common and clinically consequential, Gen Hosp Psychiatry, 37, 277, 10.1016/j.genhosppsych.2015.03.021 · DOI
  62. Gentil, 2019, Adherence to oral antihyperglycemic agents among older adults with mental disorders and its effect on health care costs, Quebec, Canada, 2005–2008, Prev Chronic Dis, 12
  63. Gibson, 2018, Patient expectations of hypertension and diabetes medication: excessive focus on short-term benefits, SAGE Open Med, 6, 1, 10.1177/2050312118821119 · DOI
  64. Gnanasan, 2011, Convergence of tuberculosis and diabetes mellitus: time to individualise pharmaceutical care, Int J Clin Pharm, 33, 44, 10.1007/s11096-010-9452-3 · DOI
  65. 10.1007/s12160-011-9268-y · DOI
  66. Grove, 2017, Evaluating the potential for primary care to serve as a mental health home for people with schizophrenia, Gen Hosp Psychiatry, 47, 14, 10.1016/j.genhosppsych.2017.03.002 · DOI
  67. Gundling, 2013, Clinical manifestations and treatment options in patients with cirrhosis and diabetes mellitus, Digestion, 87, 75, 10.1159/000343458 · DOI
  68. Gupte-Singh, 2015, Impact of comorbid depression on medication adherence and asthma-related healthcare costs in Texas Medicaid patients with asthma, J Pharm Health Serv Res, 6, 197, 10.1111/jphs.12111 · DOI
  69. 10.1503/cmaj.131807 · DOI
  70. 10.1331/JAPhA.2009.08184 · DOI
  71. Hansen, 2012, Adherence to antipsychotics and cardiometabolic medication: association with health care utilization and costs, Psychiatr Serv, 63, 920, 10.1176/appi.ps.201100328 · DOI
  72. 10.1177/1060028014563266 · DOI
  73. Hansen, 2018, Continuity of medication management among adults with schizophrenia and comorbid cardiometabolic conditions, J Pharm Health Serv Res, 9, 13, 10.1111/jphs.12201 · DOI
  74. Hapangama, 2013, Substance use disorders among mentally ill patients in a General Hospital in Sri Lanka: prevalence and correlates, Ceylon Med J, 58, 111, 10.4038/cmj.v58i3.6103 · DOI
  75. Hawke, 2013, Bipolar disorder with comorbid anxiety disorders: impact of comorbidity on treatment outcome in cognitive-behavioral therapy and psychoeducation, Int J Bipolar Disord, 1, 10.1186/2194-7511-1-15 · DOI
  76. 10.2165/11530680-000000000-00000 · DOI
  77. Ihle, 2017, Prospective and retrospective memory are differentially related to self-rated omission and commission errors in medication adherence in multimorbidity, Appl Neuropsychol Adult, 24, 505, 10.1080/23279095.2016.1209675 · DOI
  78. Iyengar, 2016, Medication nonadherence among Medicare beneficiaries with comorbid chronic conditions: influence of pharmacy dispensing channel, J Manag Care Spec Pharm, 22, 550
  79. James, 2018, Exploratory study of impact of cancer-related posttraumatic stress symptoms on diabetes self-management among cancer survivors, Psychooncology, 27, 648, 10.1002/pon.4568 · DOI
  80. Jaworski, 2011, Presence of co-morbid substance use disorder in bipolar patients worsens their social functioning to the level observed in patients with schizophrenia, Psychiatry Res, 185, 129, 10.1016/j.psychres.2010.06.005 · DOI
  81. Jing, 2011, Descriptive analysis of mail interventions with physicians and patients to improve adherence with antihypertensive and antidiabetic medications in a mixed-model managed care organization of commercial and Medicare members, J Manag Care Pharm, 17, 355
  82. Joseph, 2017, A study on prescription pattern of antihypertensive agents in chronic renal failure patients and assessment of medication adherence, Int J Pharm Sci Rev Res, 45, 72
  83. 10.1097/QAI.0b013e3181b720e7 · DOI · Paper page
  84. Kalichman, 2015, Medication adherence in people dually treated for HIV infection and mental health conditions: test of the medications beliefs framework, J Behav Med, 38, 632, 10.1007/s10865-015-9633-6 · DOI
  85. Kamal, 2018, HIV-Infected patients' beliefs about their chronic co-treatments in comparison with their combined antiretroviral therapy, HIV Med, 19, 49, 10.1111/hiv.12542 · DOI
  86. Katerndahl, 2012, Effect of comorbid depression on outcomes in diabetes and its relationship to quality of care and patient adherence: a statewide primary care ambulatory research and resources consortium study, Prim Care Companion CNS Disord, 14
  87. 10.1097/PSY.0b013e3181bd8f55 · DOI · Paper page
  88. 10.4103/1947-2714.93376 · DOI · Paper page
  89. Kenning, 2013, Primary care practitioner and patient understanding of the concepts of multimorbidity and self-management: a qualitative study, SAGE Open Med, 1, 205031211351000, 10.1177/2050312113510001 · DOI
  90. 10.1097/PSY.0b013e3181c4e3e9 · DOI
  91. Kong, 2012, Association between race, depression, and antiretroviral therapy adherence in a low-income population with HIV infection, J Gen Intern Med, 27, 1159, 10.1007/s11606-012-2043-3 · DOI
  92. Kostev, 2018, Association between depression and persistence with oral antihyperglycemic drugs in type 2 diabetes mellitus patients in Germany, Psychiatry Res, 261, 90, 10.1016/j.psychres.2017.12.058 · DOI
  93. 10.1093/schbul/sbn106 · DOI · Paper page
  94. 10.1016/j.psychres.2011.03.013 · DOI · Paper page
  95. 10.1192/bjp.bp.114.155820 · DOI
  96. Krivoy, 2017, Low adherence to antidepressants is associated with increased mortality following stroke: a large nationally representative cohort study, Eur Neuropsychopharmacol, 27, 970, 10.1016/j.euroneuro.2017.08.428 · DOI
  97. 10.1007/s12160-010-9217-1 · DOI · Paper page
  98. Krumme, 2018, Medication synchronization programs improve adherence to cardiovascular medications and health care use, Health Aff, 37, 125, 10.1377/hlthaff.2017.0881 · DOI · Paper page
  99. 10.1007/s11126-009-9100-z · DOI
  100. Langness, 2014, Comparison of adherence rates for antiretroviral, blood pressure, or mental health medications for HIV-positive patients at an academic medical center outpatient pharmacy, J Manag Care Spec Pharm, 20, 809
  101. 10.1007/s10488-010-0320-1 · DOI
  102. Li, 2016, Medication adherence and blood pressure control among hypertensive patients with coexisting long-term conditions in primary care settings: a cross-sectional analysis, Medicine, 95, 10.1097/MD.0000000000003572 · DOI
  103. 10.1370/afm.1343 · DOI · Paper page
  104. Lo Re, 2013, Adherence to hepatitis C virus therapy in HIV/hepatitis C-coinfected patients, AIDS Behav, 17, 94, 10.1007/s10461-012-0288-9 · DOI
  105. 10.2337/dc13-0051 · DOI
  106. 10.1016/J.JDIACOMP.2017.02.016 · DOI
  107. 10.1177/1078390310395586 · DOI · Paper page
  108. Mathew, 2013, Assessment of medication adherence in type-2 diabetes patients on poly pharmacy and the effect of patient counseling given to them in a Multispecialty Hospital, J Basic Clin Pharm, 5, 15, 10.4103/0976-0105.128251 · DOI
  109. 10.1016/j.jpsychores.2010.01.026 · DOI
  110. 10.1177/1090198116637601 · DOI
  111. 10.1080/09540120802001705 · DOI · Paper page
  112. 10.2196/jmir.3269 · DOI · Paper page
  113. Monroe, 2018, Randomized controlled trial of a pictorial aid intervention for medication adherence among HIV-positive patients with comorbid diabetes or hypertension, AIDS Care, 30, 199, 10.1080/09540121.2017.1360993 · DOI
  114. 10.1007/s10461-011-0072-2 · DOI · Paper page
  115. 10.1080/09540121.2012.672718 · DOI
  116. 10.1007/s10461-014-0971-0 · DOI · Paper page
  117. 10.1053/j.ajkd.2010.02.348 · DOI
  118. 10.1136/bmjopen-2016-011613 · DOI
  119. 10.1136/bmjopen-2017-017740 · DOI · Paper page
  120. Naidoo, 2013, Predictors of tuberculosis (TB) and antiretroviral (ARV) medication non-adherence in public primary care patients in South Africa: a cross sectional study, BMC Public Health, 13, 10.1186/1471-2458-13-396 · DOI · Paper page
  121. Nakimuli-Mpungu, 2019, Recruitment and baseline characteristics of participants in the social, emotional, and economic empowerment through knowledge of group support psychotherapy study (SEEK-GSP): cluster randomized controlled trial, JMIR Res Protoc, 8, 10.2196/11560 · DOI
  122. Natarajan, 2013, Adherence to antihypertensive medications among family practice patients with diabetes mellitus and hypertension, Can Fam Physician, 59, e93
  123. Nelson, 2011, Adherence to antihyperlipidemic medication and lipid control in diabetic Veterans Affairs patients with psychotic disorders, Psychosomatics, 52, 310, 10.1016/j.psym.2011.03.004 · DOI
  124. Nelson, 2011, Medication adherence and glycemic control in patients with psychotic disorders in the Veterans Affairs healthcare system, Pharm Pract, 9, 57
  125. Neugut, 2016, Nonadherence to medications for chronic conditions and nonadherence to adjuvant hormonal therapy in women with breast cancer, JAMA Oncol, 2, 1326, 10.1001/jamaoncol.2016.1291 · DOI
  126. Newville, 2015, The interaction of active substance use, depression, and antiretroviral adherence in methadone maintenance, Int J Behav Med, 22, 214, 10.1007/s12529-014-9429-z · DOI
  127. 10.1111/j.1524-4733.2008.00474.x · DOI
  128. Otenyo, 2018, Factors affecting adherence to anti-hypertensive medication regimen among hemodialysis patients attending a private hospital Mombasa, Kenya, Int J Pharm Sci Res, 9, 755
  129. Owen-Smith, 2016, Adherence to common cardiovascular medications in patients with schizophrenia vs. patients without psychiatric illness, Gen Hosp Psychiatry, 38, 9, 10.1016/j.genhosppsych.2015.07.010 · DOI · Paper page
  130. Padman, 2017, A study on prescription pattern of oral hypoglycemic agents and insulin therapy in chronic renal failure patients and assessment of medication adherence, Int J Pharm Sci Rev Res, 45, 68
  131. Pantalone, 2012, Psychosocial correlates of HIV-monoinfection and HIV/HCV-coinfection among men who have sex with men, J Behav Med, 35, 520, 10.1007/s10865-011-9381-1 · DOI
  132. Parpouchi, 2017, Characteristics of adherence to methadone maintenance treatment over a 15-year period among homeless adults experiencing mental illness, Addict Behav Rep, 6, 106
  133. Patel, 2016, Predictors of medication adherence and persistence in Medicaid enrollees with developmental disabilities and type 2 diabetes, Res Social Adm Pharm, 12, 592, 10.1016/j.sapharm.2015.09.008 · DOI
  134. Pence, 2015, The effect of antidepressant treatment on HIV and depression outcomes: results from a randomized trial, AIDS, 29, 1975, 10.1097/QAD.0000000000000797 · DOI
  135. 10.1345/aph.1L368 · DOI · Paper page
  136. Puyat, 2017, Comorbid chronic general health conditions and depression care: a population-based analysis, Psychiatr Serv, 68, 907, 10.1176/appi.ps.201600309 · DOI
  137. Qian, 2014, Association between depression and maintenance medication adherence among Medicare beneficiaries with chronic obstructive pulmonary disease, Int J Geriatr Psychiatry, 29, 49, 10.1002/gps.3968 · DOI
  138. Rattinger, 2012, The effect of dementia on medication use and adherence among Medicare beneficiaries with chronic heart failure, Am J Geriatr Pharmacother, 10, 69, 10.1016/j.amjopharm.2011.11.003 · DOI
  139. Reed, 2018, A self-management support program for older Australians with multiple chronic conditions: a randomised controlled trial, Med J Aust, 208, 69, 10.5694/mja17.00127 · DOI
  140. Rosenblum, 2014, Efficacy of dual focus mutual aid for persons with mental illness and substance misuse, Drug Alcohol Depend, 135, 78, 10.1016/j.drugalcdep.2013.11.012 · DOI · Paper page
  141. Roux, 2012, Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users, Addiction, 107, 152, 10.1111/j.1360-0443.2011.03608.x · DOI
  142. Saadat, 2015, Adherence to antihypertensives in patients with comorbid condition, Nephrourol Mon, 7, 10.5812/numonthly.29863 · DOI
  143. 10.1037/a0012715 · DOI · Paper page
  144. 10.1037/a0028208 · DOI · Paper page
  145. 10.2337/dc13-0816 · DOI · Paper page
  146. Santorelli, 2016, Effects of breast cancer on chronic disease medication adherence among older women, Pharmacoepidemiol Drug Saf, 25, 898, 10.1002/pds.3971 · DOI
  147. 10.1159/000321688 · DOI
  148. Schüz, 2011, Changes in functional health, changes in medication beliefs, and medication adherence, Health Psychol, 30, 31, 10.1037/a0021881 · DOI
  149. 10.1016/j.jpsychores.2010.07.014 · DOI · Paper page
  150. Schüz, 2014, Multiple illness perceptions in older adults: effects on physical functioning and medication adherence, Psychol Health, 29, 442, 10.1080/08870446.2013.863884 · DOI
  151. Shi, 2010, Healthcare resource utilization, adherence and persistence with antipsychotic therapy among schizophrenia patients with vs. without pre-existing metabolic syndrome, Curr Med Res Opin, 26, 2499, 10.1185/03007995.2010.519278 · DOI
  152. 10.1007/s00520-009-0802-4 · DOI
  153. Shoval, 2017, Low adherence to antidepressants is associated with increased mortality in Parkinson disease patients, Parkinsonism Relat Disord, 43, 92, 10.1016/j.parkreldis.2017.07.032 · DOI
  154. 10.1371/journal.pone.0053022 · DOI
  155. Slabbert, 2015, The impact of HIV/AIDS on compliance with antidepressant treatment in major depressive disorder: a prospective study in a South African private healthcare cohort, AIDS Res Ther, 12, 10.1186/s12981-015-0050-2 · DOI
  156. Soto, 2015, Impact of a pharmacotherapy plan to improve adherence for patients with type-2 diabetes and hypertension in a Chilean Hospital, Int J Clin Pharm, 37, 734, 10.1007/s11096-015-0131-2 · DOI
  157. 10.1177/1474651409357034 · DOI
  158. 10.1200/JOP.2014.003046 · DOI
  159. Taira, 2017, Examining factors associated with nonadherence and identifying providers caring for nonadherent subgroups, J Pharm Health Serv Res, 8, 247, 10.1111/jphs.12193 · DOI
  160. 10.1177/1054773813481801 · DOI
  161. 10.1093/arclin/acu092 · DOI
  162. 10.1016/j.dhjo.2013.02.003 · doi:10.1016/j.dhjo.2013.02.003
  163. Vatcharavongvan, 2017, Polypharmacy, medication adherence and medication management at home in elderly patients with multiple non-communicable diseases in Thai primary care, Fam Med Prim Care Rev, 19, 412, 10.5114/fmpcr.2017.70818 · DOI
  164. Vega, 2017, Impact of adherence to antidepressants on healthcare outcomes and costs among patients with type 2 diabetes and comorbid major depressive disorder, Curr Med Res Opin, 33, 1879, 10.1080/03007995.2017.1347092 · DOI
  165. Villar, 2009, Medication adherence and persistence in severe obstructive sleep apnea, Sleep, 32, 623, 10.1093/sleep/32.5.623 · DOI · Paper page
  166. 10.1007/s12160-011-9295-8 · DOI
  167. 10.1089/tmj.2011.0237 · DOI · Paper page
  168. 10.1016/j.socscimed.2013.03.012 · DOI
  169. Wei, 2018, The association of antidepressant treatment with COPD maintenance medication use and adherence in a comorbid Medicare population: a longitudinal cohort study, Int J Geriatr Psychiatry, 33, e212, 10.1002/gps.4772 · DOI
  170. Weiss, 2016, Illness perceptions, medication beliefs, and adherence to antiretrovirals and medications for comorbidities in adults with HIV infection and hypertension or chronic kidney disease, J Acquir Immune Defic Syndr, 73, 403, 10.1097/QAI.0000000000001075 · DOI
  171. Wenze, 2015, Adjunctive psychosocial intervention following hospital discharge for patients with bipolar disorder and comorbid substance use: a pilot randomized controlled trial, Psychiatry Res, 228, 516, 10.1016/j.psychres.2015.06.005 · DOI · Paper page
  172. Wong, 2014, The association between multimorbidity and poor adherence with cardiovascular medications, Int J Cardiol, 177, 477, 10.1016/j.ijcard.2014.09.103 · DOI
  173. 10.1177/0956462414535206 · DOI
  174. C-H, 2010, The association of race, comorbid anxiety, and antidepressant adherence among Medicaid enrollees with major depressive disorder, Res Social Adm Pharm, 8, 193
  175. 10.1345/aph.1P539 · DOI
  176. 10.1016/j.cardfail.2013.03.010 · DOI · Paper page
  177. 10.1007/s10549-018-4890-z · DOI
  178. Xia, 2015, Impact of mood disorder on medication adherence in patients with chronic diseases at a Shanghai rural hospital, Int J Pharmacol, 11, 518, 10.3923/ijp.2015.518.522 · DOI
  179. Xue, 2019, Treatment adherence as a mediator of blood pressure control in Chinese older adults with depression, Int J Geriatr Psychiatry, 34, 432, 10.1002/gps.5032 · DOI
  180. Yang, 2010, Nonadherence to angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers among high-risk patients with diabetes in Medicare Part D programs, J Am Pharm Assoc, 50, 527, 10.1331/JAPhA.2010.09071 · DOI
  181. 10.1016/0021-9681(87)90171-8 · DOI · Paper page
  182. 10.1080/08870446.2012.662973 · DOI
  183. 10.1016/j.ijnurstu.2014.10.010 · DOI · Paper page
  184. Pednekar, 2019, Methods for measuring multiple medication adherence: a systematic Review-Report of the ISPOR medication adherence and persistence special interest group, Value Health, 22, 139, 10.1016/j.jval.2018.08.006 · DOI
  185. 10.1176/appi.ps.58.2.207 · DOI · Paper page
  186. 10.4088/JCP.8001tx17c · DOI · Paper page
  187. 10.1186/s12877-019-1031-4 · DOI
  188. Dezii, 2002, Effects of once-daily and twice-daily dosing on adherence with prescribed glipizide oral therapy for type 2 diabetes, South Med J, 95, 68, 10.1097/00007611-200295010-00014 · doi:10.1097/00007611-200295010-00014 · Paper page
  189. 10.1038/s41598-018-23276-8 · DOI · Paper page
  190. Khan, 2018, Challenges and innovations of drug delivery in older age, Adv Drug Deliv Rev, 135, 3, 10.1016/j.addr.2018.09.003 · DOI
  191. 10.1007/s40266-014-0153-9 · DOI
  192. 10.1016/j.cger.2012.01.008 · DOI · Paper page
  193. Lam, 2015, Medication adherence measures: an overview, Biomed Res Int, 2015, 1
  194. 10.2165/00002512-200421120-00004 · DOI · Paper page

Cited by

See all 208

Metadata

Authors
Foley, L., Larkin, J., Lombard-Vance, R., Murphy, A. W., Hynes, L., Galvin, E., & Molloy, G. J.
Venue
BMJ Open
Publisher
BMJ
Published
2021-09
Volume
11
Issue
9
Pages
e044987
ISSN
2044-6055 (ISSN-L)
OpenAlex
W3197047107
Cited by
208
References
19
FWCI
8.66
Type
journal article
Language
en
Open access
gold
Funders
Health Research Board (CDA-2018-003)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.